{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:53Z","timestamp":1707524273603},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,4]]},"DOI":"10.7759\/cureus.16159","type":"journal-article","created":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:11:41Z","timestamp":1625397101000},"source":"Crossref","is-referenced-by-count":0,"title":["Novel Presentation of Aphasia and Tremor in Immune-Mediated Necrotizing Myopathy"],"prefix":"10.7759","author":[{"given":"Gabriella","family":"Schmuter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian A","family":"Paniagua-Morales","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1402225","article-title":"Inflammatory muscle diseases","volume":"372","author":"Dalakas MC","year":"2015","unstructured":"Dalakas MC. Inflammatory muscle diseases. N Engl J Med. 2015, 372:1734-47. 10.1056\/NEJMra1402225","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2016.12.025","article-title":"Diagnosis and management of immune-mediated myopathies","volume":"92","author":"Milone M","year":"2017","unstructured":"Milone M. Diagnosis and management of immune-mediated myopathies. Mayo Clin Proc. 2017, 92:826-37. 10.1016\/j.mayocp.2016.12.025","journal-title":"Mayo Clin Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12524","article-title":"Diagnosis and classification of idiopathic inflammatory myopathies","volume":"280","author":"Lundberg IE","year":"2016","unstructured":"Lundberg IE, Miller FW, Tj\u00e4rnlund A, Bottai M. Diagnosis and classification of idiopathic inflammatory myopathies. J Intern Med. 2016, 280:39-51. 10.1111\/joim.12524","journal-title":"J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7500","article-title":"A rare case of statin-induced immune-mediated necrotizing myopathy","volume":"12","author":"Madgula AS","year":"2020","unstructured":"Madgula AS, Gadela NV, Singh M, Chen K. A rare case of statin-induced immune-mediated necrotizing myopathy. Cureus. 2020, 12:e7500. 10.7759\/cureus.7500","journal-title":"Cureus"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7963","article-title":"Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy","volume":"12","author":"Stroie OP","year":"2020","unstructured":"Stroie OP, Boster J, Surry L. Statin-induced immune-mediated necrotizing myopathy: an increasingly recognized inflammatory myopathy. Cureus. 2020, 12:e7963. 10.7759\/cureus.7963","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1207","article-title":"Clinical features and treatment outcomes of necrotizing autoimmune myopathy","volume":"72","author":"Kassardjian CD","year":"2015","unstructured":"Kassardjian CD, Lennon VA, Alfugham NB, Mahler M, Milone M. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015, 72:996-1003. 10.1001\/jamaneurol.2015.1207","journal-title":"JAMA Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-2891-4","article-title":"Idiopathic inflammatory myopathies - a review","volume":"34","author":"Jones J","year":"2015","unstructured":"Jones J, Wortmann R. Idiopathic inflammatory myopathies - a review. Clin Rheumatol. 2015, 34:839-44. 10.1007\/s10067-015-2891-4","journal-title":"Clin Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.1397","article-title":"Tremor","volume":"311","author":"Elias WJ","year":"2014","unstructured":"Elias WJ, Shah BB. Tremor. JAMA. 2014, 311:948-54. 10.1001\/jama.2014.1397","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200522020-00006","article-title":"Poststroke aphasia: epidemiology, pathophysiology and treatment","volume":"22","author":"Berthier ML","year":"2005","unstructured":"Berthier ML. Poststroke aphasia: epidemiology, pathophysiology and treatment. Drugs Aging. 2005, 22:163-82. 10.2165\/00002512-200522020-00006","journal-title":"Drugs Aging"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7827","article-title":"Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report","volume":"12","author":"Marotta DA","year":"2020","unstructured":"Marotta DA, Zadourian A, Jabaay MJ, Kesserwani A, Kesserwani H. Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report. Cureus. 2020, 12:e7827. 10.7759\/cureus.7827","journal-title":"Cureus"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7049","article-title":"The value of intravenous immunoglobulin therapy in idiopathic inflammatory myositis in the current transformed era of biologics","volume":"12","author":"Patwardhan A","year":"2020","unstructured":"Patwardhan A. The value of intravenous immunoglobulin therapy in idiopathic inflammatory myositis in the current transformed era of biologics. Cureus. 2020, 12:e7049. 10.7759\/cureus.7049","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30254-0","article-title":"Classification and management of adult inflammatory myopathies","volume":"17","author":"Selva-O\u2019Callaghan A","year":"2018","unstructured":"Selva-O\u2019Callaghan A, Pinal-Fernandez I, Trallero-Aragu\u00e1s E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol. 2018, 17:816-28. 10.1016\/S1474-4422(18)30254-0","journal-title":"Lancet Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/1756286421998918","article-title":"Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series","volume":"14","author":"Xiong A","year":"2021","unstructured":"Xiong A, Yang G, Song Z, et al.. Rituximab in the treatment of immune-mediated necrotizing myopathy: a review of case reports and case series. Ther Adv Neurol Disord. 2021, 14:1756286421998918. 10.1177\/1756286421998918","journal-title":"Ther Adv Neurol Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.226440","article-title":"Tremor syndromes: a review","volume":"66","author":"Kamble N","year":"2018","unstructured":"Kamble N, Pal PK. Tremor syndromes: a review. Neurol India. 2018, 66:S36-47. 10.4103\/0028-3886.226440","journal-title":"Neurol India"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3233\/RNN-150632","article-title":"The pathophysiology of post-stroke aphasia: a network approach","volume":"34","author":"Thiel A","year":"2016","unstructured":"Thiel A, Zumbansen A. The pathophysiology of post-stroke aphasia: a network approach. Restor Neurol Neurosci. 2016, 34:507-18. 10.3233\/RNN-150632","journal-title":"Restor Neurol Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-018-0891-x","article-title":"Aphasia recovery: when, how and who to treat?","volume":"18","author":"Doogan C","year":"2018","unstructured":"Doogan C, Dignam J, Copland D, Leff A. Aphasia recovery: when, how and who to treat?. Curr Neurol Neurosci Rep. 2018, 18:90. 10.1007\/s11910-018-0891-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.rehab.2019.06.015","article-title":"New factors that affect quality of life in patients with aphasia","volume":"63","author":"Bullier B","year":"2020","unstructured":"Bullier B, Cassoudesalle H, Villain M, et al.. New factors that affect quality of life in patients with aphasia. Ann Phys Rehabil Med. 2020, 63:33-7. 10.1016\/j.rehab.2019.06.015","journal-title":"Ann Phys Rehabil Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.11.1533","article-title":"Steroid treatment of primary progressive aphasia","volume":"65","author":"Decker DA","year":"2008","unstructured":"Decker DA, Heilman KM. Steroid treatment of primary progressive aphasia. Arch Neurol. 2008, 65:1533-5. 10.1001\/archneur.65.11.1533","journal-title":"Arch Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/49798-novel-presentation-of-aphasia-and-tremor-in-immune-mediated-necrotizing-myopathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:37Z","timestamp":1707507097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/49798-novel-presentation-of-aphasia-and-tremor-in-immune-mediated-necrotizing-myopathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,4]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.16159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,4]]}}}